Sh Park - Samsung Medical Center, Sungkyunkwan University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 30 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Bifidobacterium species BB_003 enhances antitumor immunity in patients with NMIBC and improve recurrence-free survival

Min K.,Piao X-M., Kim S-K.,Park S-H.,Kang H.W.,Kim W.T., Kim K.,Park H.P.,Yun S.J.

European Urology (2023): S869

引用0浏览0引用

LBA6 EV-302/KEYNOTE-A39: Open-label, Randomized Phase III Study of Enfortumab Vedotin in Combination with Pembrolizumab (EV+P) Vs Chemotherapy (chemo) in Previously Untreated Locally Advanced Metastatic Urothelial Carcinoma (La/muc)

T.B. Powles,B. Perez Valderrama, S. Gupta,J. Bedke,E. Kikuchi,J. Hoffman-Censits,G. Iyer,C. Vulsteke,S.H. Park,S.J. Shin,D.E. Castellano Gauna,G. Fornarini,J-R. Li,M. Gumus,N. Mar, S. Narayanan, X. Yu,S. Gorla, B.M.S. Homet Moreno van der Heijden

Annals of Oncology (2023): S1340

引用10浏览0引用

2359O Phase III THOR Study: Results of Erdafitinib (erda) Vs Pembrolizumab (pembro) in Pretreated Patients (pts) with Advanced or Metastatic Urothelial Cancer (muc) with Select Fibroblast Growth Factor Receptor Alterations (Fgfralt)

A. O. Siefker-Radtke,N. Matsubara,S. H. Park,R. A. Huddart,E. F. Burgess,M. Ozguroglu,B. Perez Valderrama,S. Triantos,S. Akapame,Y. Kean,K. Deprince, S. Mukhopadhyay,Y. Loriot

Annals of oncology (2023): S1199-S1199

引用0浏览0引用

EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV plus P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

T. B. Powles,B. Perez Valderrama,S. Gupta,J. Bedke,E. Kikuchi,J. Hoffman-Censits,G. Iyer,C. Vulsteke,S. H. Park,S. J. Shin,D. E. Castellano Gauna,G. Fornarini,J-R. Li,M. Gumus,N. Mar, S. Narayanan, X. Yu,S. Gorla, B. M. S. Homet Moreno van der Heijden

ANNALS OF ONCOLOGY (2023): S1340-S1340

引用0浏览0引用

Cost-effective and time-saving 3-D printing protocol of intraabdominal cavity of liver transplantation recipient to prevent large-for-size syndrome

J. Rhu, J. M. Kim,G. -S. Choi,J. -W. Joh,S. H. Park,M. Lim,J. H. Yang,J. Kwon, E. S. Jeong, S. O. Yoon

TRANSPLANTATION（2022）

引用0浏览0引用

PD-L1 and Immune Infiltrates Are Differentially Expressed in Distinct Subgroups of Gastric Cancer

H. K. Angell, J. Lee,K-M. Kim,K. Kim, S-T. Kim,S. H. Park,W. K. Kang,A. Sharpe, J. Ogden,A. Davenport,D. R. Hodgson,J. C. Barrett,E. Kilgour

Oncoimmunology（2018）

引用47浏览0WOS引用

A Pilot Study of Exercise Intervention During Chemotherapy in Patients with Metastatic Cancer

H. K. Ahn,Y. S. Kim, E. Y. Kim,K. D. Park,I. Park,S. J. Sym,S. H. Park,D. B. Shin

Annals of oncology（2018）

引用0浏览0WOS引用

Treatment with ionomycin improves pregnancy rates in poor responders

J. S. Koo, H. Lee,H. S. Moon,S. E. Moon,S. H. Park,S. H. Min

HUMAN REPRODUCTION（2016）

引用0浏览0引用

Translational Oncology Volume 8 Number 4 August 2015 pp. 279–287 279

Y Koh,I Park, CH Sun,S Lee,H Yun, CK Park,SH Park, JK Park, SH Lee

user-5f8411ab4c775e9685ff56d3（2015）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn